The Federal Government says over 29 million eligible persons have received the 1st dose of the COVID-19 vaccines noting that this represents 23.4% Nigeria’s eligible population.
It further said 14,179,966 persons have received the 2nd dose and 17,702,018 are fully vaccinated which represent 15.8% of its eligible population while 1,178,604 persons have received the booster dose.
The Executive Director of the National Primary Health Care Development Agency Dr. Faisal Shuaib disclosed this on Tuesday while receiving 4.4 million doses of the Johnson and Johnson COVID-19 vaccine donated by Spain to Nigeria.
According to him, these figures shows that Nigeria is a far cry from its target of 70% of its eligible population but however noted that these donations will help towards achieving its target.
Dr. Shuaib said if we keep up with vaccination, the likely scenario is that even though the virus continues to evolve, the severity of the disease will reduce over time, as the immunity increases due to vaccination.
He however said If majority of our eligible population in Nigeria and globally continue to remain unvaccinated, what we may see is that a more virulent and highly transmissible variant could emerge, sooner or later which would be worse than any variant seen.
He said striving to vaccinate 70% of the eligible population of every country remains essential for bringing the pandemic under control and Nigeria is working hard to ensure its citizens has access to the lifesaving vaccines.
He assured that they will continue to work with all stakeholders, partners and communities to ensure an inclusive COVID-19 vaccination campaign in Nigeria.
The Spain Ambassador to Nigeria Juan Ignatio Sell, in his remark, said there is need to protect, safeguard and invest in health and health workers, adding that this is the effort line that Spain is co-leading in the framework of the Global Action Plan.
He added that they have committed 300 million euros for further donations and projects to strengthen public health systems.
He also harped on the need to improve global mechanisms for technology transfer to decentralize the production of health products in all regions, Africa in particular.